Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains
Authors:
- 27 May 2015
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 55 (9) , 2104-2112
Abstract
BACKGROUND: To increase blood safety, various procedures are currently implemented, including donor selection, optimized donor arm disinfection, and diversion. In addition, pathogen inactivation (PI) techniques can be used for platelets (PLTs) and plasma concentrates.STUDY DESIGN AND METHODS: This study investigated the clinical efficacy of an inactivation technique for different blood components at two time points (12 and 35.5 hr). Eight transfusion‐relevant bacterial strains were spiked at two different concentrations (100 and 1000 colony‐forming units [CFUs]/bag) into whole blood (WB), apheresis PLTs (APs), and buffy coat (BC)‐derived minipool PLTs.RESULTS: The bacterial concentrations were higher than 106 CFUs/mL within 24 hours after spiking depending on the particular bacterial strain. PI was absolute for all of the APs performed 12 hours after inoculation, but the bacterial strains of Klebsiella pneumoniae and Bacillus cereus were not completely inactivated in WB or BC PLTs, performed 35.5 and 12 hours after inoculation, respectively.CONCLUSION: The INTERCEPT PI system was not 100% effective for high concentrations of certain K. pneumoniae strains or spore‐forming B. cereus. A critical observation was that the period between blood donation and inactivation needs to be minimal to enable efficient PI. In the case where PI cannot be performed immediately after preparation, a combination of a PI technology after the production of blood components with a rapid bacterial screen test on Day 4 or 5 after donation may offer a solution to further prevent the risk of bacterial transmission by transfusion.Keywords
Funding Information
- Cerus Corporation
This publication has 50 references indexed in Scilit:
- Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology systemTransfusion, 2012
- Evaluation of the VersaTREK System Compared to the Bactec MGIT 960 System for First-Line Drug Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2012
- Testing platelet components for bacterial contaminationTransfusion and Apheresis Science, 2011
- A comparison of methods of pathogen inactivation of FFPVox Sanguinis, 2011
- Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTMTransfusion Medicine and Hemotherapy, 2011
- UVC Irradiation for Pathogen Reduction of Platelet Concentrates and PlasmaTransfusion Medicine and Hemotherapy, 2011
- Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010)Transfusion Medicine and Hemotherapy, 2011
- Transfusion medicine and safetyBiologicals, 2009
- Thermal Probing of E. coli RNA Polymerase Off-Pathway MechanismsJournal of Molecular Biology, 2008
- Comparison of the BACTEC 9240 and BacT/Alert Blood Culture Systems for Detection of Bacterial Contamination in Platelet ConcentratesJournal of Clinical Microbiology, 2006